Can we really hope to slow down the ageing process? The compound nicotinamide mononucleotide (NMN) has shown plenty of promise at increasing the lifespans of mice, and is about to be put to the test in human clinical trials for the first time. Next month, 10 healthy volunteers will be given NMN to see if it can slow down ageing without any harmful side-effects. If the results are positive and the drug is given the all-clear for public use, it’ll be the first genuine anti-ageing product on the market.
From our very good friends over at sciencealert. com
Click Here for the Full Article
Please support our Sponsors